[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-340950-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-340950-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","prediction-of-methylation-status-using-wgs-data-of-plasma-cfdna-for-multi-cancer-early-detection-mced","Prediction of methylation status using WGS data of plasma cfDNA for multi-cancer early detection (MCED)","","Cell-free DNA (cfDNA) carries molecular information that supports multi-cancer early detection (MCED), including epigenetic changes such as cfDNA fragmentation patterns. Since cfDNA fragmentation is non-random and may relate to cfDNA methylation, this study tests clinical feasibility of inferring cfDNA methylation levels from fragmentation. Whole-genome bisulfite sequencing and whole-genome sequencing (WGS) were performed on healthy individuals and cancer patients to analyze CpG cleavage profiles and validate CpG-level methylation prediction using WGS data.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/prediction-of-methylation-status-using-wgs-data-of-plasma-cfdna-for-multi-cancer-early-detection-mced/340950/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/prediction-of-methylation-status-using-wgs-data-of-plasma-cfdna-for-multi-cancer-early-detection-mced/340950.png","ImageObject",300,407,{"name":42,"@type":43},"Anda","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-07","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",13,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How does the study link cfDNA fragmentation to methylation status for MCED?","Question",{"text":63,"@type":64},"The study argues that cfDNA fragmentation is non-random and may be related to cfDNA methylation. It therefore tests whether CpG cleavage profiles derived from WGS data can be used to infer methylation levels.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What sequencing approaches are used in the analysis?",{"text":68,"@type":64},"The study uses whole-genome bisulfite sequencing (WGBS) and whole-genome sequencing (WGS). WGBS provides methylation-level information, while WGS is used to analyze CpG cleavage profiles for prediction.",{"name":70,"@type":61,"acceptedAnswer":71},"What is the main outcome of the modeling results?",{"text":72,"@type":64},"Modeling shows feasibility to predict methylation status of individual CpG sites in cfDNA using cleavage profile models built from WGS data.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},340950,1790181635,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":124,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},962075006959,"https://ap-avatar.wpscdn.com/avatar/e0002397efbe92a78e?_k=1776741047341049297","Cui et al. Clinical Epigenetics (2024) 16:34 [https://doi.org/10.1186/s13148-024-01646-6](https://doi.org/10.1186/s13148-024-01646-6)  \nClinical Epigenetics  \n METHODOLOGY Open Access  \nPrediction of methylation status using WGS data of plasma cfDNA for multi-cancer early detection (MCED)  \nPin Cui1*†, Xiaozhou Zhou2†, Shu Xu3†, Weihuang He1†, Guozeng Huang4, Yong Xiong4, Chuxin Zhang5, Tingmin Chang6, Mingji Feng1, Hanming Lai 1 andYi Pan7*  \nAbstract  \nBackground Cell-free DNA (cfDNA) contains a large amount of molecular information that can be used for multicancer early detection (MCED), including changes in epigenetic status of cfDNA, such as cfDNA fragmentation profile. The fragmentation of cfDNA is non-random and may be related to cfDNA methylation. This study provides clinical evidence for the feasibility of inferring cfDNA methylation levels based on cfDNA fragmentation patterns. We performed whole-genome bisulfite sequencing and whole-genome sequencing (WGS) on both healthy individuals and cancer patients. Using the information of whole-genome methylation levels, we investigated cytosine–phosphate–guanine (CpG) cleavage profile and validated the method of predicting the methylation level of individual CpG sites using WGS data.  \nResults We conducted CpG cleavage profile biomarker analysis on data from both healthy individuals and cancer patients. We obtained unique or shared potential biomarkers for each group and built models accordingly. The modeling results proved the feasibility to predict the methylation status of single CpG sites in cfDNA using cleavage profile model from WGS data.  \nConclusion By combining cfDNA cleavage profile of CpG sites with machine learning algorithms, we have identified specific CpG cleavage profile as biomarkers to predict the methylation status of individual CpG sites. Therefore, methylation profile, a widely used epigenetic biomarker, can be obtained from a single WGS assay for MCED.  \nKeywords Methylation status, Multi-cancer early detection, WGS, WGBS, cfDNA fragmentation profile  \n†Pin Cui, Xiaozhou Zhou, Shu Xu and Weihuang He have contributed equally to this article.  \n*Correspondence: Pin Cui [cuipin@rafabio.com](cuipin@rafabio.com)[ ](cuipin@rafabio.com)Yi Pan [yi.pan@siat.ac.cn](yi.pan@siat.ac.cn)  \n1 Shenzhen Rapha Biotechnology Incorporate, Shenzhen 518118, China  \n2 Department of Liver Disease, Shenzhen Traditional Chinese Medicine Hospital, Shenzhen 518033, China  \n3 Department of Oncology, Shenzhen Hospital, University of Chinese Academy of Sciences, Shenzhen 518106, China  \n4 Department of Hepatobiliary Gastrointestinal Surgery, Shenzhen Hospital, University of Chinese Academy of Sciences, Shenzhen 518106, China  \n5 Department of Gastroenterology, Shenzhen Hospital, University of Chinese Academy of Sciences, Shenzhen 518106, China  \n6 Department of Endoscopy, The First Affiliated Hospital of Xinxiang Medical University, Weihui 453100, China  \n7 Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by/4.0/](http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Do","cbCaijCHMoXWBLZL","https://ap.wps.com/l/cbCaijCHMoXWBLZL","pdf",1713473,"English","# Abstract\n# Introduction\n# Methods\n## Participant recruitment and study design\n## CpG cleavage profile biomarker analysis\n# Results\n# Conclusion","[{\"question\":\"How does the study link cfDNA fragmentation to methylation status for MCED?\",\"answer\":\"The study argues that cfDNA fragmentation is non-random and may be related to cfDNA methylation. It therefore tests whether CpG cleavage profiles derived from WGS data can be used to infer methylation levels.\"},{\"question\":\"What sequencing approaches are used in the analysis?\",\"answer\":\"The study uses whole-genome bisulfite sequencing (WGBS) and whole-genome sequencing (WGS). WGBS provides methylation-level information, while WGS is used to analyze CpG cleavage profiles for prediction.\"},{\"question\":\"What is the main outcome of the modeling results?\",\"answer\":\"Modeling shows feasibility to predict methylation status of individual CpG sites in cfDNA using cleavage profile models built from WGS data.\"}]","Prediction of methylation status using WGS data of plasma cfDNA for multi-cancer early detection (MCED) | PDF",1790039667,25,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0137b74dd0205b84ce0d86c7e7f25a23.webp",983,1305,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d0fc6dd703466c96d127349ba4e76af8.webp",982,1304,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fd41fde5ae67f4b63d56e40620772e6a.webp",981,1303,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4d21f7393c6bae48d5b24e2b9fcefd80.webp",980,1301]